MetaADEDB 2.0 @ LMMD
Memantine
(LDDHMLJTFXJGPI-UHFFFAOYSA-N)
Structure
SMILES
CC12CC3CC(C1)(C)CC(C2)(C3)N.Cl
Molecular Formula:
C12H22ClN
Molecular Weight:
215.763
Log P:
4.1964
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
2
TPSA:
26.02
CAS Number(s):
41100-52-1
Synonym(s)
1.
Memantine
2.
1,3-Dimethyl-5-aminoadamantane
3.
1-Amino-3,5-dimethyladamantane
4.
Axura
5.
D-145
6.
D145
7.
Ebixa
8.
Memantin
9.
Memantine Hydrochloride
10.
Namenda
11.
D 145
External Link(s)
MeSHD008559
PubChem Compound181458
66766747
43834392
ChEBI64323
CHEMBLCHEMBL1699
KEGGdr:D04905
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 166US FAERS
2AstheniaFAERS: 86US FAERS
3SomnolenceFAERS: 81US FAERS
4NauseaFAERS: 74US FAERS
5FatigueFAERS: 73US FAERS
6HeadacheFAERS: 71US FAERS
7AgitationFAERS: 61US FAERS
8VomitingFAERS: 56US FAERS
9ConstipationFAERS: 52US FAERS
10Drug ineffectiveFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
11PneumoniaFAERS: 37US FAERS
12DementiaFAERS: 33US FAERS
13SyncopeFAERS: 33US FAERS
14MalaiseFAERS: 31US FAERS
15DehydrationFAERS: 27US FAERS
16Disease ProgressionFAERS: 26US FAERS
17LethargyFAERS: 26US FAERS
18Back PainFAERS: 25US FAERS
19Drug dose omissionFAERS: 25US FAERS
20General physical health deteriorationFAERS: 24US FAERS
21Memory impairmentFAERS: 24US FAERS
22Urinary tract infectionFAERS: 24US FAERS
23DeliriumFAERS: 23US FAERS
24Pulmonary EmbolismFAERS: 23US FAERS
25Weight decreasedFAERS: 23US FAERS
26SepsisFAERS: 21US FAERS
27Feeling abnormalFAERS: 20US FAERS
28Malignant neoplasm progressionFAERS: 20US FAERS
29TremorFAERS: 20US FAERS
30Cerebrovascular accidentFAERS: 19US FAERS
31HypotensionFAERS: 19US FAERS
32PainFAERS: 18US FAERS
33AnorexiaFAERS: 17US FAERS
34AnxietyFAERS: 16US FAERS
35Failure to ThriveFAERS: 16US FAERS
36Urinary IncontinenceFAERS: 16US FAERS
37Abdominal PainFAERS: 15US FAERS
38ArthralgiaFAERS: 15US FAERS
39Mental status changesFAERS: 15US FAERS
40Myocardial InfarctionFAERS: 15US FAERS
41Chest PainFAERS: 14US FAERS
42CryingFAERS: 14US FAERS
43DysarthriaFAERS: 14US FAERS
44Accidental overdoseFAERS: 13US FAERS
45DisorientationFAERS: 13US FAERS
46EpilepsyFAERS: 13US FAERS
47AbasiaFAERS: 12US FAERS
48AmnesiaFAERS: 12US FAERS
49Blood glucose increasedFAERS: 12US FAERS
50Deep Vein ThrombosisFAERS: 12US FAERS
51ParanoiaFAERS: 12US FAERS
52RestlessnessFAERS: 12US FAERS
53HypersomniaFAERS: 11US FAERS
54Lung consolidationFAERS: 11US FAERS
55Activities of daily living impairedFAERS: 10US FAERS
56PalpitationsFAERS: 10US FAERS
57Atrial FibrillationFAERS: 9US FAERS
58Blood creatinine increasedFAERS: 9US FAERS
59Depressed moodFAERS: 9US FAERS
60HypophagiaFAERS: 9US FAERS
61Musculoskeletal stiffnessFAERS: 9US FAERS
62MyoclonusFAERS: 9US FAERS
63Respiratory FailureFAERS: 9US FAERS
64Abdominal discomfortFAERS: 8US FAERS
65AngerFAERS: 8US FAERS
66InfectionFAERS: 8US FAERS
67Intentional product misuseFAERS: 8US FAERS
68Medication ErrorFAERS: 8US FAERS
69OverdoseFAERS: 8US FAERS
70PancreatitisFAERS: 8US FAERS
71ApathyFAERS: 7US FAERS
72BradycardiaFAERS: 7US FAERS
73MyalgiaFAERS: 7US FAERS
74No adverse eventFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
75PruritusFAERS: 7US FAERS
76TachycardiaFAERS: 7US FAERS
77Unevaluable eventFAERS: 7US FAERS
78Unresponsive to stimuliFAERS: 7US FAERS
79VertigoFAERS: 7US FAERS
80AphasiaFAERS: 6US FAERS
81Blood sodium decreasedFAERS: 6US FAERS
82Blood urea increasedFAERS: 6US FAERS
83ChillsFAERS: 6US FAERS
84Completed SuicideFAERS: 6US FAERS
85DiplopiaFAERS: 6US FAERS
86HemiparesisFAERS: 6US FAERS
87Hospice CareFAERS: 6US FAERS
88HypomaniaFAERS: 6US FAERS
89Incorrect dose administeredFAERS: 6US FAERS
90NervousnessFAERS: 6US FAERS
91PneumonitisFAERS: 6US FAERS
92Status EpilepticusFAERS: 6US FAERS
93TinnitusFAERS: 6US FAERS
94Adverse eventFAERS: 5US FAERS
95Alanine Aminotransferase IncreasedFAERS: 5US FAERS
96Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
97Blood sodium increasedFAERS: 5US FAERS
98CatatoniaFAERS: 5US FAERS
99DroolingFAERS: 5US FAERS
100DysuriaFAERS: 5US FAERS
101HypoxiaFAERS: 5US FAERS
102PallorFAERS: 5US FAERS
103Peripheral swellingFAERS: 5US FAERS
104PneumothoraxFAERS: 5US FAERS
105Rash erythematousFAERS: 5US FAERS
106StaringFAERS: 5US FAERS
107ThrombocytopeniaFAERS: 5US FAERS
108Acute kidney injuryFAERS: 4US FAERS
109Arteriosclerosis ObliteransFAERS: 4US FAERS
110AtelectasisFAERS: 4US FAERS
111Atrioventricular BlockFAERS: 4US FAERS
112Blood alkaline phosphatase increasedFAERS: 4US FAERS
113Burning sensationFAERS: 4US FAERS
114DeafnessFAERS: 4US FAERS
115Depressed Level of ConsciousnessFAERS: 4US FAERS
116Diet refusalFAERS: 4US FAERS
117Drug dispensing errorFAERS: 4US FAERS
118DysgeusiaFAERS: 4US FAERS
119Euphoric moodFAERS: 4US FAERS
120HemiplegiaFAERS: 4US FAERS
121Hypertensive crisisFAERS: 4US FAERS
122HypokinesiaFAERS: 4US FAERS
123Oropharyngeal painFAERS: 4US FAERS
124PemphigusFAERS: 4US FAERS
125PresyncopeFAERS: 4US FAERS
126Productive CoughFAERS: 4US FAERS
127ScreamingFAERS: 4US FAERS
128Therapeutic response unexpectedFAERS: 4US FAERS
129Urinary RetentionFAERS: 4US FAERS
130UrticariaFAERS: 4US FAERS
131AbscessFAERS: 3US FAERS
132BlindnessFAERS: 3US FAERS
133Blood glucose decreasedFAERS: 3US FAERS
134Blood urine presentFAERS: 3US FAERS
135Bone painFAERS: 3US FAERS
136CellulitisFAERS: 3US FAERS
137Cerebral InfarctionFAERS: 3US FAERS
138CholelithiasisFAERS: 3US FAERS
139ClumsinessFAERS: 3US FAERS
140Diabetes MellitusFAERS: 3US FAERS
141Drug administration errorFAERS: 3US FAERS
142Drug ineffective for unapproved indicationFAERS: 3US FAERS
143Erectile dysfunctionFAERS: 3US FAERS
144ErythemaFAERS: 3US FAERS
145GoutFAERS: 3US FAERS
146IleusFAERS: 3US FAERS
147Inappropriate schedule of drug administrationFAERS: 3US FAERS
148InfarctionFAERS: 3US FAERS
149InflammationFAERS: 3US FAERS
150Intestinal ObstructionFAERS: 3US FAERS
151Joint stiffnessFAERS: 3US FAERS
152LeukocytosisFAERS: 3US FAERS
153Lip swellingFAERS: 3US FAERS
154Loss of personal independence in daily activitiesFAERS: 3US FAERS
155Macular degenerationFAERS: 3US FAERS
156Metastatic NeoplasmFAERS: 3US FAERS
157Musculoskeletal PainFAERS: 3US FAERS
158Musculoskeletal chest painFAERS: 3US FAERS
159Neck PainFAERS: 3US FAERS
160Paradoxical drug reactionFAERS: 3US FAERS
161Personality ChangeFAERS: 3US FAERS
162PhlebitisFAERS: 3US FAERS
163PhotophobiaFAERS: 3US FAERS
164Poor peripheral circulationFAERS: 3US FAERS
165Septic ShockFAERS: 3US FAERS
166Sinus TachycardiaFAERS: 3US FAERS
167Sleep TalkingFAERS: 3US FAERS
168Slow speechFAERS: 3US FAERS
169Stevens-Johnson SyndromeFAERS: 3US FAERS
170StomatitisFAERS: 3US FAERS
171Suicide attemptFAERS: 3US FAERS
172Therapy cessationFAERS: 3US FAERS
173Toxicity to various agentsFAERS: 3US FAERS
174Transaminases increasedFAERS: 3US FAERS
175Visual ImpairmentFAERS: 3US FAERS
176WheezingFAERS: 3US FAERS
177White blood cell count decreasedFAERS: 3US FAERS
178Wrong technique in product usage processFAERS: 3US FAERS
179jaundiceFAERS: 3US FAERS
180nervous system disorderFAERS: 3US FAERS
181Abnormal sleep-related eventFAERS: 2US FAERS
182Accidental drug intake by childFAERS: 2US FAERS
183Adrenal massFAERS: 2US FAERS
184AlopeciaFAERS: 2US FAERS
185AneurysmFAERS: 2US FAERS
186AngioedemaFAERS: 2US FAERS
187AtaxiaFAERS: 2US FAERS
188BedriddenFAERS: 2US FAERS
189BelligerenceFAERS: 2US FAERS
190Blood creatine phosphokinase increasedFAERS: 2US FAERS
191Blood potassium increasedFAERS: 2US FAERS
192Blood prolactin increasedFAERS: 2US FAERS
193BronchopneumoniaFAERS: 2US FAERS
194BruxismFAERS: 2US FAERS
195Cancer PainFAERS: 2US FAERS
196Cardiac ArrestFAERS: 2US FAERS
197Catheter site cellulitisFAERS: 2US FAERS
198Catheter site painFAERS: 2US FAERS
199Catheter site swellingFAERS: 2US FAERS
200Central nervous system lesionFAERS: 2US FAERS
201Chest discomfortFAERS: 2US FAERS
202ChokingFAERS: 2US FAERS
203ChromaturiaFAERS: 2US FAERS
204Cognitive deteriorationFAERS: 2US FAERS
205Complex partial seizuresFAERS: 2US FAERS
206Drug abuseFAERS: 2US FAERS
207Drug level increasedFAERS: 2US FAERS
208Drug prescribing errorFAERS: 2US FAERS
209Drug titration errorFAERS: 2US FAERS
210DyspepsiaFAERS: 2US FAERS
211DystoniaFAERS: 2US FAERS
212Electrolyte imbalanceFAERS: 2US FAERS
213Emotional disorderFAERS: 2US FAERS
214EncephalitisFAERS: 2US FAERS
215EndocarditisFAERS: 2US FAERS
216EnuresisFAERS: 2US FAERS
217EpistaxisFAERS: 2US FAERS
218Extra dose administeredFAERS: 2US FAERS
219Facial paralysisFAERS: 2US FAERS
220Febrile infectionFAERS: 2US FAERS
221Feeling ColdFAERS: 2US FAERS
222Flat affectFAERS: 2US FAERS
223FlatulenceFAERS: 2US FAERS
224GastritisFAERS: 2US FAERS
225Grip strength decreasedFAERS: 2US FAERS
226Hepatic cancer metastaticFAERS: 2US FAERS
227HydropneumothoraxFAERS: 2US FAERS
228HypervigilanceFAERS: 2US FAERS
229Impaired self-careFAERS: 2US FAERS
230IncoherentFAERS: 2US FAERS
231IncontinenceFAERS: 2US FAERS
232Incorrect drug administration durationFAERS: 2US FAERS
233InfluenzaFAERS: 2US FAERS
234Intentional drug misuseFAERS: 2US FAERS
235Intentional self-injuryFAERS: 2US FAERS
236Intervertebral Disc DegenerationFAERS: 2US FAERS
237Joint injuryFAERS: 2US FAERS
238Joint swellingFAERS: 2US FAERS
239Labile blood pressureFAERS: 2US FAERS
240Leukocytoclastic vasculitisFAERS: 2US FAERS
241LeukopeniaFAERS: 2US FAERS
242Limb injuryFAERS: 2US FAERS
243Lipase increasedFAERS: 2US FAERS
244LymphadenopathyFAERS: 2US FAERS
245LymphomaFAERS: 2US FAERS
246MetastasisFAERS: 2US FAERS
247Muscle CrampFAERS: 2US FAERS
248Muscle RigidityFAERS: 2US FAERS
249MydriasisFAERS: 2US FAERS
250Myoclonic EpilepsyFAERS: 2US FAERS
251Negative thoughtsFAERS: 2US FAERS
252NeutropeniaFAERS: 2US FAERS
253Night sweatsFAERS: 2US FAERS
254No adverse effectFAERS: 2US FAERS
255NystagmusFAERS: 2US FAERS
256Optic NeuropathyFAERS: 2US FAERS
257PancytopeniaFAERS: 2US FAERS
258Performance status decreasedFAERS: 2US FAERS
259Product quality issueFAERS: 2US FAERS
260Product substitution issueFAERS: 2US FAERS
261Pulmonary InfarctionFAERS: 2US FAERS
262Respiratory distressFAERS: 2US FAERS
263RetchingFAERS: 2US FAERS
264Retinal vascular thrombosisFAERS: 2US FAERS
265Skin UlcerFAERS: 2US FAERS
266SluggishnessFAERS: 2US FAERS
267StressFAERS: 2US FAERS
268ThrombophlebitisFAERS: 2US FAERS
269ThrombosisFAERS: 2US FAERS
270Ventricular FibrillationFAERS: 2US FAERS
271Violence-related symptomFAERS: 2US FAERS
272Visual disturbanceFAERS: 2US FAERS
273Abdominal AbscessFAERS: 1US FAERS
274Accidental exposure to productFAERS: 1US FAERS
275Acute myocardial infarctionFAERS: 1US FAERS
276AgeusiaFAERS: 1US FAERS
277AkathisiaFAERS: 1US FAERS
278Alanine aminotransferase decreasedFAERS: 1US FAERS
279Alcohol interactionFAERS: 1US FAERS
280Altered state of consciousnessFAERS: 1US FAERS
281Ammonia increasedFAERS: 1US FAERS
282Anal inflammationFAERS: 1US FAERS
283AnorgasmiaFAERS: 1US FAERS
284Anticoagulation drug level above therapeuticFAERS: 1US FAERS
285Anticoagulation drug level below therapeuticFAERS: 1US FAERS
286Anticonvulsant drug level decreasedFAERS: 1US FAERS
287Aortic AneurysmFAERS: 1US FAERS
288AppendicitisFAERS: 1US FAERS
289Arrhythmogenic Right Ventricular DysplasiaFAERS: 1US FAERS
290ArthritisFAERS: 1US FAERS
291AsphyxiaFAERS: 1US FAERS
292AsthenopiaFAERS: 1US FAERS
293AsthmaFAERS: 1US FAERS
294Atrial FlutterFAERS: 1US FAERS
295AuraFAERS: 1US FAERS
296Autonomic nervous system imbalanceFAERS: 1US FAERS
297Axillary vein thrombosisFAERS: 1US FAERS
298Bacillus infectionFAERS: 1US FAERS
299Back disorderFAERS: 1US FAERS
300Biliary dilatationFAERS: 1US FAERS
301BlepharospasmFAERS: 1US FAERS
302Blood albumin decreasedFAERS: 1US FAERS
303Blood amylase increasedFAERS: 1US FAERS
304Blood chloride decreasedFAERS: 1US FAERS
305Blood chloride increasedFAERS: 1US FAERS
306Blood cholesterol increasedFAERS: 1US FAERS
307Blood lactate dehydrogenase increasedFAERS: 1US FAERS
308Blood pressure inadequately controlledFAERS: 1US FAERS
309Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
310Blood urea nitrogen/creatinine ratio decreasedFAERS: 1US FAERS
311Bowel movement irregularityFAERS: 1US FAERS
312BronchospasmFAERS: 1US FAERS
313Bulimia NervosaFAERS: 1US FAERS
314Cerebellar AtaxiaFAERS: 1US FAERS
315Cerebral hypoperfusionFAERS: 1US FAERS
316CholestasisFAERS: 1US FAERS
317ChoreaFAERS: 1US FAERS
318Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
319Clostridium test positiveFAERS: 1US FAERS
320ColitisFAERS: 1US FAERS
321Concomitant disease aggravatedFAERS: 1US FAERS
322CoprolaliaFAERS: 1US FAERS
323Corneal thickeningFAERS: 1US FAERS
324Creatinine renal clearance decreasedFAERS: 1US FAERS
325Creatinine renal clearance increasedFAERS: 1US FAERS
326CyanosisFAERS: 1US FAERS
327Decreased eye contactFAERS: 1US FAERS
328Delusion of replacementFAERS: 1US FAERS
329Delusional disorder, unspecified typeFAERS: 1US FAERS
330Delusional perceptionFAERS: 1US FAERS
331DermatitisFAERS: 1US FAERS
332Diabetes mellitus inadequate controlFAERS: 1US FAERS
333DisabilityFAERS: 1US FAERS
334Disease recurrenceFAERS: 1US FAERS
335Diverticular perforationFAERS: 1US FAERS
336DiverticulitisFAERS: 1US FAERS
337Drug dose titration not performedFAERS: 1US FAERS
338Drug effect incompleteFAERS: 1US FAERS
339Dry skinFAERS: 1US FAERS
340DysgraphiaFAERS: 1US FAERS
341DysphasiaFAERS: 1US FAERS
342DysphemiaFAERS: 1US FAERS
343DysphoniaFAERS: 1US FAERS
344Economic problemFAERS: 1US FAERS
345EczemaFAERS: 1US FAERS
346Electroencephalogram abnormalFAERS: 1US FAERS
347Embolic strokeFAERS: 1US FAERS
348Emotional distressFAERS: 1US FAERS
349EmpyemaFAERS: 1US FAERS
350EnteritisFAERS: 1US FAERS
351EructationFAERS: 1US FAERS
352Erythema MultiformeFAERS: 1US FAERS
353Escherichia infectionFAERS: 1US FAERS
354Excessive masturbationFAERS: 1US FAERS
355Expired product administeredFAERS: 1US FAERS
356Eye InfectionFAERS: 1US FAERS
357Eye irritationFAERS: 1US FAERS
358Eye painFAERS: 1US FAERS
359Feeling jitteryFAERS: 1US FAERS
360Fluid overloadFAERS: 1US FAERS
361Foreign body sensation in eyesFAERS: 1US FAERS
362FractureFAERS: 1US FAERS
363Gait inabilityFAERS: 1US FAERS
364Gastrointestinal sounds abnormalFAERS: 1US FAERS
365Gastrointestinal stromal cancerFAERS: 1US FAERS
366Gaze palsyFAERS: 1US FAERS
367General symptomFAERS: 1US FAERS
368GliosisFAERS: 1US FAERS
369HalitosisFAERS: 1US FAERS
370Hallucinations, mixedFAERS: 1US FAERS
371Head discomfortFAERS: 1US FAERS
372Hepatic EncephalopathyFAERS: 1US FAERS
373HerniaFAERS: 1US FAERS
374HostilityFAERS: 1US FAERS
375HungerFAERS: 1US FAERS
376HydrocephalusFAERS: 1US FAERS
377HyperchlorhydriaFAERS: 1US FAERS
378HyperphagiaFAERS: 1US FAERS
379HypersensitivityFAERS: 1US FAERS
380Hypoaesthesia facialFAERS: 1US FAERS
381Hyporesponsive to stimuliFAERS: 1US FAERS
382Idiopathic Pulmonary FibrosisFAERS: 1US FAERS
383ImmobileFAERS: 1US FAERS
384Immune tolerance inductionFAERS: 1US FAERS
385Impaired driving abilityFAERS: 1US FAERS
386Impaired quality of lifeFAERS: 1US FAERS
387Incorrect product administration durationFAERS: 1US FAERS
388Increased upper airway secretionFAERS: 1US FAERS
389Initial insomniaFAERS: 1US FAERS
390Injection site extravasationFAERS: 1US FAERS
391Intentional misuseFAERS: 1US FAERS
392Intercepted drug dispensing errorFAERS: 1US FAERS
393Intestinal PerforationFAERS: 1US FAERS
394Intracranial massFAERS: 1US FAERS
395Joint sprainFAERS: 1US FAERS
396Lack of spontaneous speechFAERS: 1US FAERS
397Limb discomfortFAERS: 1US FAERS
398Long QT SyndromeFAERS: 1US FAERS
399Lymphocyte count abnormalFAERS: 1US FAERS
400Malignant ascitesFAERS: 1US FAERS
401Mallory-Weiss SyndromeFAERS: 1US FAERS
402MalnutritionFAERS: 1US FAERS
403Mastication disorderFAERS: 1US FAERS
404Medication residue presentFAERS: 1US FAERS
405Mental impairmentFAERS: 1US FAERS
406Metastases to adrenalsFAERS: 1US FAERS
407Metastatic painFAERS: 1US FAERS
408Metastatic uterine cancerFAERS: 1US FAERS
409Middle insomniaFAERS: 1US FAERS
410Mood swingsFAERS: 1US FAERS
411Morbid thoughtsFAERS: 1US FAERS
412Mouth swellingFAERS: 1US FAERS
413NasopharyngitisFAERS: 1US FAERS
414NephrolithiasisFAERS: 1US FAERS
415Nerve injuryFAERS: 1US FAERS
416NeuritisFAERS: 1US FAERS
417Neurological decompensationFAERS: 1US FAERS
418NocturiaFAERS: 1US FAERS
419NoduleFAERS: 1US FAERS
420Noninfective encephalitisFAERS: 1US FAERS
421Nuchal RigidityFAERS: 1US FAERS
422Nutritional condition abnormalFAERS: 1US FAERS
423Obsessive-Compulsive DisorderFAERS: 1US FAERS
424ObstructionFAERS: 1US FAERS
425Occult blood positiveFAERS: 1US FAERS
426Ophthalmic vein thrombosisFAERS: 1US FAERS
427Oral candidiasisFAERS: 1US FAERS
428OsteopeniaFAERS: 1US FAERS
429Oxygen consumption increasedFAERS: 1US FAERS
430Pancreatic carcinomaFAERS: 1US FAERS
431Pancreatic duct dilatationFAERS: 1US FAERS
432Pathological doubtFAERS: 1US FAERS
433Pericardial effusionFAERS: 1US FAERS
434PeritonitisFAERS: 1US FAERS
435PerseverationFAERS: 1US FAERS
436PetechiaeFAERS: 1US FAERS
437Physical deconditioningFAERS: 1US FAERS
438PneumocephalusFAERS: 1US FAERS
439Poor quality sleepFAERS: 1US FAERS
440Postrenal failureFAERS: 1US FAERS
441PregnancyFAERS: 1US FAERS
442Pressure of speechFAERS: 1US FAERS
443Product dose omissionFAERS: 1US FAERS
444Product label issueFAERS: 1US FAERS
445Product packaging quantity issueFAERS: 1US FAERS
446Product physical issueFAERS: 1US FAERS
447Product use complaintFAERS: 1US FAERS
448Product use issueFAERS: 1US FAERS
449Protein urine presentFAERS: 1US FAERS
450Psychomotor skills impairedFAERS: 1US FAERS
451Pulmonary congestionFAERS: 1US FAERS
452Pulmonary thrombosisFAERS: 1US FAERS
453Reaction to azo-dyesFAERS: 1US FAERS
454Respiratory arrestFAERS: 1US FAERS
455Respiratory tract congestionFAERS: 1US FAERS
456RhabdomyolysisFAERS: 1US FAERS
457ScabFAERS: 1US FAERS
458ScotomaFAERS: 1US FAERS
459Secretion dischargeFAERS: 1US FAERS
460Sexual activity increasedFAERS: 1US FAERS
461Sinus ArrhythmiaFAERS: 1US FAERS
462Sinus bradycardiaFAERS: 1US FAERS
463Skin reactionFAERS: 1US FAERS
464SoliloquyFAERS: 1US FAERS
465Spinal column stenosisFAERS: 1US FAERS
466Sputum culture positiveFAERS: 1US FAERS
467StarvationFAERS: 1US FAERS
468Sudden deathFAERS: 1US FAERS
469Supraventricular tachycardiaFAERS: 1US FAERS
470SwellingFAERS: 1US FAERS
471Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
472Tardive DyskinesiaFAERS: 1US FAERS
473TensionFAERS: 1US FAERS
474Terminal stateFAERS: 1US FAERS
475TetanyFAERS: 1US FAERS
476Therapy changeFAERS: 1US FAERS
477ThirstFAERS: 1US FAERS
478Throat cancerFAERS: 1US FAERS
479Throat irritationFAERS: 1US FAERS
480Thrombotic strokeFAERS: 1US FAERS
481Tongue bitingFAERS: 1US FAERS
482Tonic clonic movementsFAERS: 1US FAERS
483ToothacheFAERS: 1US FAERS
484Troponin increasedFAERS: 1US FAERS
485UlcerFAERS: 1US FAERS
486Unexpected therapeutic drug effectFAERS: 1US FAERS
487Urinary casts presentFAERS: 1US FAERS
488Urine bilirubin increasedFAERS: 1US FAERS
489Urine leukocyte esterase positiveFAERS: 1US FAERS
490VasculitisFAERS: 1US FAERS
491Vertebral foraminal stenosisFAERS: 1US FAERS
492Walking aid userFAERS: 1US FAERS
493Wheelchair userFAERS: 1US FAERS
494Wrong drug administeredFAERS: 1US FAERS
495Wrong technique in drug usage processFAERS: 1US FAERS
496XanthopsiaFAERS: 1US FAERS
497treatment failureFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.